help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on July 15, 2004
Molecular Endocrinology, doi:10.1210/me.2004-0167
A more recent version of this article appeared on November 1, 2004
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
18/11/2790    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, J.
Right arrow Articles by Randeva, H. S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, J.
Right arrow Articles by Randeva, H. S

Submitted on April 20, 2004
Accepted on July 8, 2004

Genomic Organization of Mouse Orexin Receptors: Characterization of Two Novel Tissue-Specific Splice Variants

Jing Chen and Harpal S Randeva*

Molecular Medicine Group, Biological Sciences, University of Warwick, UK

* To whom correspondence should be addressed. E-mail: hrandeva{at}bio.warwick.ac.uk.

In humans and rat, orexins orchestrate divergent actions through their G-protein coupled receptors, orexin-1 (OX1R) and orexin-2 (OX2R). Orexins also play an important physiological role in mouse, but the receptors through which they function are not characterized. To characterize the physiological role(s) of orexins in the mouse, we cloned and characterized the mouse orexin receptor(s), mOX1R and mOX2R, using Rapid Amplification of cDNA (mouse brain) Ends (RACE), RT-PCR and gene structure analysis. The mOX1R cDNA encodes a 416 amino acid receptor. We have identified two alternative C-terminus splice variants of the mOX2R; mOX2{alpha}R (443 aa) and mOX2{beta}R (460 aa). Binding studies in HEK-293 cells transfected with mOX1R, mOX2{alpha}R and the mOX2{beta}R revealed specific, saturable sites for both orexin-A and -B. Activation of these receptors by orexins induced inositol triphosphates (IP3) turnover. However, HEK-293 cells transfected with mOXRs demonstrated no cAMP response to either orexin-A or orexin-B challenge, although forskolin and GTP{gamma}S revealed a dose-dependent increase in cAMP. Although, orexin-A and orexin-B showed no difference in binding characteristics between the splice variants, interestingly, orexin-B led to an increase in IP3 production at all concentrations in the mOX2{beta}R variant. Orexin-A however, showed no difference in IP3 production between the two variants. Additionally, in the mouse, we demonstrate that these splice variants are distributed in a tissue specific manner, where OX2{alpha}R mRNA was undetectable in skeletal muscle and kidney. Moreover, food deprivation led to a greater increase in hypothalamic mOX2{beta}R gene expression, compared with both mOX1R and mOX2{alpha}R. This potentially implicates a fundamental physiological role for these splice variants.


Key words: Mouse • Orexin receptors • Receptor subtype • Inositol triphosphates (IP3) • Food deprivation







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society